comparemela.com

Pushkal Garg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75.

Rhode islandUnited statesTolga tangulerRaymond jamesMaury raycroftPushkal gargGary nachmanJeff poultonChristine lindenboomPaul matteisDavid lebowitzYvonne greenstreetAlnylam pharmaceuticals quarterCorporate communications at alnylamAlnylam pharmaceuticals incAlnylam pharmaceuticals

Is Alnylam s HELIOS-B Delay A Red Flag? (NASDAQ:ALNY)

Is Alnylam s HELIOS-B Delay A Red Flag? (NASDAQ:ALNY)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Pushkal gargHuge opportunityTransthyretin amyloidosis

Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.1, expectations were $-1.2.

United statesChristine lindenboomPushkal gargKostas biliourisEllie merleAkshay vaishnawJeff poultonPaul matteisYvonne greenstreetTolga tangulerFastest growing companiesAlnylam pharmaceuticals incCorporate communications at alnylamAlnylam pharmaceuticalsCall transcript februarySenior vice president

Alnylam changes to heart drug trial spark doubts, sinking shares

BioPharma

Pushkal gargAkshay vaishnawYvonne greenstreetBio pharmaAlnylam pharmaceuticalsDive briefBridgebio pharmaClinical trials

Alnylam changes analysis plan for key Amvuttra heart trial, jolting investors

Alnylam changes analysis plan for key Amvuttra heart trial, jolting investors
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

William blairPushkal gargYvonne greenstreet

vimarsana © 2020. All Rights Reserved.